Ketogenic diet improves metabolic markers, shows promise for bipolar disorder and schizophrenia symptoms in first RCT, partly funded by Baszucki Group ...
Vesalio, a global leader in vascular intervention, announced that results from the randomized NATURE clinical trial evaluating the enVast™ Coronary Thrombectomy System will be presented in a ...
Summary: Researchers demonstrated that a ketogenic diet, which shifts the body away from glucose and toward fat-derived ketones for fuel, induces rapid metabolic improvements and alleviates persistent ...
July 8, 2026 expert reaction to RCT on efficacy of anti-histamines, anti-inflammatory, and blood thinner drugs on long Covid-related fatigue . A randomised controlled trial publis ...
Cholibrium combines ten mushroom extracts targeting heart health as Reishi and Shiitake cardiovascular research matures ...
Mesoblast Achieves Target of 300 Treated Patients in Pivotal Phase 3 Trial for Chronic Low Back Pain
Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has achieved its target of at least 300 patients treated in ...
Pain medicine physicians from across the U.S. will continue to expand their knowledge on the broad applications for the SPRINT PNS System at the American Society of Pain & Neuroscience (ASPN) Annual ...
Patients with "bone-on-bone" arthritis, PRP produced sustained pain and function and measurable shifts in cartilage ...
Outcomes of the HeartMate 3 device vary by age, with younger patients showing better survival and less bleeding events and ...
Picture a second grader who is struggling to read at a school trying hard to fix that. He gets his regular classroom lessons, ...
Serious mental illnesses such as schizophrenia and bipolar 1 disorder can have a major effect on a person’s daily life.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results